The PBM lobby said that the vendor role in the Trump administration’s Medicare Part B demo should be filled by entities such as pharmacy benefit managers or specialty pharmacies, but not by manufacturers in comments submitted to HHS and CMS on Thursday (Dec. 6) . The administration had pegged manufacturers among several entities that might act as middlemen between manufacturers and providers to negotiate for lower prices. Pharmaceutical Care Management Association called for CMS to ban manufacturers from participating in...